MYNERVA
LIVE

Serial Number

79415731

Owner

Greta Preatoni

Attorney

JULIANNE ABELMAN

Filing Date

Nov 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MYNERVA Trademark

Serial Number: 79415731

MYNERVA is a trademark filed by Greta Preatoni on November 8, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Greta Preatoni (2 trademarks)

Weinbergstrasse 35

Entity Type: 98

Trademark Details

Filing Date

November 8, 2024

Registration Date

Not Registered

Published for Opposition

February 10, 2026

Goods & Services

Medical apparatus, namely, nerve stimulator apparatus; medical instruments, namely, electrotherapy devices for providing sensory restoration, infrared heat and compression; orthopedic articles, namely, orthopedic compression garments and hosiery; suture materials; therapeutic devices adapted for persons with disabilities, namely, electronic stimulation apparatus for muscles for physical therapy purposes; massage apparatus; therapeutic and assistive devices, namely, walking prosthesis adapted for persons with disabilities; medical instruments, namely, electrotherapy devices for providing sensory restoration; orthopedic articles, namely, graduated compression hosiery and elastic stockings for medical purposes; medical instruments, namely, electronic nerve stimulators for medical purposes.

Scientific and measuring apparatus and instruments, namely, wearable sensory prosthesis devices in the nature of electronically controlled garments and hosiery for detecting and processing gait, pressure, and movement data; signaling apparatus, namely, transmitters of electronic signals for use in neurostimulation, not for medical or therapeutic purposes; computers and computer peripheral devices, namely, wearable computer hardware in the nature of electronic control units for use with sensor-controlled neurostimulation systems, not for medical or therapeutic purposes; measuring apparatus, namely, wearable sensor-based devices for monitoring gait, balance, pressure and movement; measuring instruments, namely, wearable sensory prosthesis devices for remote monitoring of peripheral neuropathy; measuring apparatus, namely, haptic suits, other than for medical purposes; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; measuring apparatus, namely, pressure recorders; electronic downloadable publications, namely, books, magazines, journals for use by medical professionals in the field of science and medicine; measurement apparatus, namely, pressure sensors, other than for medical use, pressure indicators, and pressure measuring apparatus; scientific apparatus, namely, data processing apparatus; measuring apparatus, namely, electronic sensors for detecting biomechanical data, not for medical use; downloadable computer software applications for therapy customization of adaptive sensory prosthesis for peripheral neuropathy; downloadable software for signal analysis, data visualization and therapeutic control of wearable devices; downloadable computer software for logging and monitoring of neurostimulation and sensory restoration therapies for peripheral neuropathy; downloadable and recorded computer software for wireless content delivery; recorded and downloadable computer software platforms for remote monitoring and adjust therapeutic plans for sensory prosthesis and neurostimulative treatment of diabetic neuropathy; downloadable computer software for communicating with users of hand-held computers; downloadable computer software for application and database integration; downloadable software as a medical device (SaMD) for therapeutic control and personalization of sensory prosthesis and neurostimulative treatment in diabetic neuropathy; downloadable mobile applications for controlling wearable neurostimulation devices, visualizing gait and pressure sensor data, and tracking therapeutic outcomes in users with peripheral neuropathy.

Scientific and technological services, namely, research and design in the field of computer networking hardware, computer datacenter architecture, wearable sensor technology, neurostimulation systems, and medical data analysis software; industrial analysis and research services in the field of wearable neurotechnology and gait monitoring; industrial design services relating to wearable medical devices; quality control for others of wearable therapeutic devices; authentication of data in the field of medical signal processing systems using secure and trusted encryption mechanisms, public key infrastructure (PKI) and digital signature technologies; design and development of wearable computers, sensor-based hardware, and medical software.

Filing History

EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 12, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2025 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 9, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 9, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 9, 2025 COAR
REFUSAL PROCESSED BY IB
Jul 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 20, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 20, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 11, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 10, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 2, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 30, 2025 REPR